2023-01-23 07:09:57 AMK AssetMark Financial
01/23/23 01/2307:09 01/23/2307:09 | JPMorgan upgrades AssetMark Financial on medium term positionJPMorgan analyst Michael Cho upgraded AssetMark Financial to Overweight from Neutral with a price target of $32, up from $24. The analyst thinks the independent advisor space will continue to benefit from industry secular tailwinds. The service providers that cater to independent financial advisors continue to gain traction, the firm tells investors in a research note. Despite the uncertain near-term market and macro backdrop, companies like AssetMark remain well positioned over the medium term, JPMorgan contends. The analyst says the wealth industry is benefitting from a rise in demand for financial advice while the wirehouses continue to cede share. The firm upgraded small-cap idea AssetMark on expectations for continued solid execution, self-help margin expansion, its higher sensitivity to markets, and an "unassuming" valuation. |
---|
Downgrade
|
SSAB AB downgraded to Equal Weight from Overweight at Morgan Stanley »
04:44 02/03/23 02/0304:44 02/03/2304:44
SSAAY
SSAB AB
Morgan Stanley analyst… Story temporarily locked. ShowHide Related Items >><<
|
Downgrade
|
Friedrich Vorwerk downgraded to Hold from Buy at Berenberg »
04:43 02/03/23 02/0304:43 02/03/2304:43
FRVWY
Friedrich Vorwerk
Berenberg analyst Lasse… Story temporarily locked. ShowHide Related Items >><<
|
Downgrade
|
Asos downgraded to Hold from Buy at Deutsche Bank »
04:40 02/03/23 02/0304:40 02/03/2304:40
ASOMY
Asos
Deutsche Bank analyst… Story temporarily locked. ShowHide Related Items >><<
|
Downgrade
|
Pets at Home Group downgraded to Hold from Buy at Deutsche Bank »
04:39 02/03/23 02/0304:39 02/03/2304:39
PAHGF
Pets at Home Group
Deutsche Bank analyst… Story temporarily locked. ShowHide Related Items >><<
|
Downgrade
|
Kingfisher downgraded to Hold from Buy at Deutsche Bank »
04:39 02/03/23 02/0304:39 02/03/2304:39
KGFHY
Kingfisher
Deutsche Bank analyst… Story temporarily locked. ShowHide Related Items >><<
|
Upgrade
|
Inditex upgraded to Hold from Sell at Deutsche Bank »
04:38 02/03/23 02/0304:38 02/03/2304:38
IDEXY
Inditex
Deutsche Bank analyst… Story temporarily locked. ShowHide Related Items >><<
|
Upgrade
|
B&M European Value Retail upgraded to Buy from Hold at Deutsche Bank »
04:37 02/03/23 02/0304:37 02/03/2304:37
BMRRY
B&M European Value Retail
Deutsche Bank analyst… Story temporarily locked. ShowHide Related Items >><<
|
Upgrade
|
Marks & Spencer upgraded to Buy from Hold at Deutsche Bank »
04:37 02/03/23 02/0304:37 02/03/2304:37
MAKSY
Marks & Spencer
Deutsche Bank analyst… Story temporarily locked. ShowHide Related Items >><<
|
Upgrade
|
Standard Chartered upgraded to Buy from Hold at Investec »
04:34 02/03/23 02/0304:34 02/03/2304:34
SCBFF
Standard Chartered
Investec analyst Ian… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Amazon.com price target raised to $123 from $119 at Piper Sandler »
04:32 02/03/23 02/0304:32 02/03/2304:32
AMZN
Amazon.com
Piper Sandler analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Alphabet price target lowered to $120 from $122 at Piper Sandler »
04:30 02/03/23 02/0304:30 02/03/2304:30
GOOGL
Alphabet
Alphabet
Piper Sandler analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Gilead price target raised to $112 from $111 at Piper Sandler »
04:28 02/03/23 02/0304:28 02/03/2304:28
GILD
Gilead
Piper Sandler analyst Do… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Conmed price target raised to $118 from $108 at Piper Sandler »
04:27 02/03/23 02/0304:27 02/03/2304:27
CNMD
Conmed
Piper Sandler analyst… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
Privia Health initiated with a Buy at Goldman Sachs »
04:26 02/03/23 02/0304:26 02/03/2304:26
PRVA
Privia Health
Goldman Sachs analyst… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
Agios Pharmaceuticals initiated with an Overweight at Piper Sandler »
04:25 02/03/23 02/0304:25 02/03/2304:25
AGIO
Agios Pharmaceuticals
Piper Sandler analyst… Story temporarily locked. ShowHide Related Items >><<
|
General news
| Market Update: Asian… Story temporarily locked. ShowHide Related Items >><<
|
General news
|
China economy bounces back thanks to services. »
02:25 02/03/23 02/0302:25 02/03/2302:25
$ECON
Economic Data
China economy bounces… Story temporarily locked. ShowHide Related Items >><<
|
Conference/Events
|
Piper Sandler economist to hold an analyst/industry conference call »
22:33 02/02/23 02/0222:33 02/02/2322:33
Chief Economist Lazar and… Chief Economist Lazar and Head of Global Policy Perli discuss payrolls and their implications on an Analyst/Industry conference call to be held on February 3 at 8:45 am. Webcast Link |
Conference/Events
|
Cowen medical devices analyst to hold analyst/industry conference call »
22:24 02/02/23 02/0222:24 02/02/2322:24
Medical Devices Analyst… Medical Devices Analyst Jennings, along with Dr. Shephal Doshi, Director of Cardiac Electrophysiology at Pacific Heart Institute, discuss the market dynamics of the U.S. Left Atrial Appendage Closure (LAAC) Duopoly on an Analyst/Industry conference call to be held on February 7 at 12:30 pm. Webcast Link |
Syndicate
|
Avalo Therapeutics 3.77M share Spot Secondary priced at $3.98 »
21:56 02/02/23 02/0221:56 02/02/2321:56
AVTX
Avalo Therapeutics
SVB Securities and RBC… SVB Securities and RBC Capital are acting as joint book running managers for the offering. ShowHide Related Items >><<
|
Recommendations
|
Conmed price target raised to $118 from $108 at Piper Sandler »
21:55 02/02/23 02/0221:55 02/02/2321:55
CNMD
Conmed
Piper Sandler analyst… Piper Sandler analyst Matt O'Brien raised the firm's price target on Conmed to $118 from $108 and keeps an Overweight rating on the shares. The company unsurprisingly missed on Q4 earnings and revenue due to a previously disclosed Software Implementation issue, but this should be a transitory factor, the analyst tells investors in a research note. Conmed's key growth drivers - the Smoke business, In2Bones and Biorez - remain strong and should stay that way through 2023 and beyond, the firm adds. ShowHide Related Items >><<
|
Syndicate
|
Roivant Sciences 26.67M share Secondary priced at $7.50 »
21:17 02/02/23 02/0221:17 02/02/2321:17
ROIV
Roivant Sciences
The deal size was… The deal size was increased to $200M from $150M and priced below last closing price of $7.59. Goldman Sachs, SVB Securities, Cowen and Cantor Fitzgerald are acting as joint book running managers for the offering. ShowHide Related Items >><<
|
Syndicate
|
Edible Garden 1.62M share Spot Secondary priced at $6.30 »
20:43 02/02/23 02/0220:43 02/02/2320:43
EDBL
Edible Garden
The deal priced below… The deal priced below last closing price of $8.35. Maxim and Joseph Gunnar are acting as joint book running managers for the offering. ShowHide Related Items >><<
|
Hot Stocks
|
Dutch Bros CEO sells $6.0M in common stock »
20:39 02/02/23 02/0220:39 02/02/2320:39
BROS
Dutch Bros
In a regulatory filing,… In a regulatory filing, Dutch Bros disclosed that its CEO Jonathan Ricci sold 160K shares of common stock on February 1 in a total transaction size of $6.0M. ShowHide Related Items >><<
|
Earnings
|
Notable companies reporting before tomorrow's open »
20:25 02/02/23 02/0220:25 02/02/2320:25
CI
Cigna
Regeneron
Zimmer Biomet
Church & Dwight
Saia
Notable companies… Notable companies reporting before tomorrow's open, with earnings consensus, include Cigna (CI), consensus $4.86... Regneron (REGN), consensus $10.03... Zimmer Biomet (ZBH), consensus $1.83... Church & Dwight (CHD), consensus 60c... Saia (SAIA), consensus $2.83. ShowHide Related Items >><<
|